Journal
Frontiers in Pediatrics
Publication Date
1-1-2024
Volume
12
First Page
1341762
Document Type
Open Access Publication
DOI
10.3389/fped.2024.1341762
Rights and Permissions
L’Hotta AJ, Spence A, Varughese TE, Felts K, Hayashi SS, Jones-White M, LaFentres E, Lieu JEC, Hayashi RJ and King AA (2024) Children with non-central nervous system tumors treated with platinum-based chemotherapy are at risk for hearing loss and cognitive impairments. Front. Pediatr. 12:1341762. doi: 10.3389/fped.2024.1341762 © 2024 L’Hotta, Spence, Varughese, Felts, Hayashi, Jones-White, LaFentres, Lieu, Hayashi and King. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
L'Hotta, Allison J; Spence, Anne; Varughese, Taniya E; Felts, Kara; Hayashi, Susan S; Jones-White, Megan; LaFentres, Emily; Lieu, Judith E C; Hayashi, Robert J; and King, Allison A, "Children with non-central nervous system tumors treated with platinum-based chemotherapy are at risk for hearing loss and cognitive impairments." Frontiers in Pediatrics. 12, 1341762 (2024).
https://digitalcommons.wustl.edu/oa_4/5830
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
